Prevention of Recurrence After Resection of Hepatocellular Carcinoma: A Daunting Challenge

被引：109
作者：
Poon, Ronnie T. P. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2011年 / 54卷 / 03期
关键词：
CURATIVE RESECTION; RANDOMIZED-TRIAL; RISK-FACTORS; INTERFERON; VITAMIN-K2; METAANALYSIS; EXPRESSION; HEPATITIS; THERAPY; LIVER;
D O I：
10.1002/hep.24569
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：757 / 759
页数：3
相关论文
共 21 条
  • [1] Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis
    Breitenstein, S.
    Dimitroulis, D.
    Petrowsky, H.
    Puhan, M. A.
    Muellhaupt, B.
    Clavien, P. -A.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (09) : 975 - 981
  • [2] Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma A 20-Year Experience
    Fan, Sheung Tat
    Lo, Chung Mau
    Poon, Ronnie T. P.
    Yeung, Chun
    Liu, Chi Leung
    Yuen, Wai Key
    Lam, Chi Ming
    Ng, Kelvin K. C.
    Chan, See Ching
    [J]. ANNALS OF SURGERY, 2011, 253 (04) : 745 - 758
  • [3] Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver
    Habu, D
    Shiomi, S
    Tamori, A
    Takeda, T
    Tanaka, T
    Kubo, S
    Nishiguchi, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (03): : 358 - 361
  • [4] Hotta N, 2007, HEPATO-GASTROENTEROL, V54, P2073
  • [5] Preventive effects of vitamin K on recurrent disease in patients with hepatocellular carcinoma arising from hepatitis C viral infection
    Kakizaki, Satoru
    Sohara, Naondo
    Sato, Ken
    Suzuki, Hideyuki
    Yanagisawa, Masatoshi
    Nakajima, Hiroaki
    Takagi, Hitoshi
    Naganuma, Atsushi
    Otsuka, Toshiyuki
    Takahashi, Hitomi
    Hamada, Tetsuya
    Mori, Masatomo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (04) : 518 - 522
  • [6] Kuriyama S, 2005, INT J ONCOL, V27, P505
  • [7] Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial
    Lau, WY
    Leung, TWT
    Ho, SKW
    Chan, M
    Machin, D
    Lau, J
    Chan, ATC
    Yeo, W
    Mok, TSK
    Yu, SCH
    Leung, NWY
    Johnson, PJ
    [J]. LANCET, 1999, 353 (9155) : 797 - 801
  • [8] Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
    Liu, Chun-Jen
    Lee, Po-Huang
    Lin, Deng-Yn
    Wu, Cheng-Chung
    Jeng, Long-Bin
    Lin, Pin-Wen
    Mok, King-Tong
    Lee, Wei-Chen
    Yeh, Hong-Zen
    Ho, Ming-Chih
    Yang, Sheng-Shun
    Lee, Ching-Chih
    Yu, Ming-Chin
    Hu, Rey-Heng
    Peng, Cheng-Yuan
    Lai, Kuan-Lang
    Chang, Stanley Shi-Chung
    Chen, Pei-Jer
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (05) : 958 - 968
  • [9] Sorafenib in advanced hepatocellular carcinoma
    Llovet, Josep M.
    Ricci, Sergio
    Mazzaferro, Vincenzo
    Hilgard, Philip
    Gane, Edward
    Blanc, Jean-Frederic
    Cosme de Oliveira, Andre
    Santoro, Armando
    Raoul, Jean-Luc
    Forner, Alejandro
    Schwartz, Myron
    Porta, Camillo
    Zeuzem, Stefan
    Bolondi, Luigi
    Greten, Tim F.
    Galle, Peter R.
    Seitz, Jean-Francois
    Borbath, Ivan
    Haussinger, Dieter
    Giannaris, Tom
    Shan, Minghua
    Moscovici, Marius
    Voliotis, Dimitris
    Bruix, Jordi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) : 378 - 390
  • [10] A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma
    Lo, Chung Mau
    Liu, Chi Leung
    Chan, See Ching
    Lam, Chi Ming
    Poon, Ronnie T. P.
    Ng, Irene O. L.
    Fan, Sheung Tat
    Wong, John
    [J]. ANNALS OF SURGERY, 2007, 245 (06) : 831 - 842
123